The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...

A 20-year-old Indian doctoral student was shot dead near the University of Toronto Scarborough campus, with authorities ...

Mondego Bio selects PTPN2 inhibitor clinical candidate and targets first-in-human trials in H1 2026: Cantanhede, Portugal Tuesday, December 23, 2025, 17:00 Hrs [IST] Mondego Bio, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

It can be a real pain in the neck. Rheumatoid arthritis, or RA, is an autoimmune disease in which the body mistakenly attacks ...

With this milestone, Mondego Bio is transitioning into clinical-stage operations and plans to initiate a first-in-human (FIH) ...

Learn how CBG may support inflammation, gut health, stress, and sleep in 2026, with a science-informed guide to safe, ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is a novel, highly selective inhibitor of the mutated Janus kinase 2 (JAK2) V617F variant ...

Inflammatory molecules circulating in the blood may worsen disease symptoms and points to new opportunities for targeted therapy.

REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in preclinical models ...